Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...

Related Keywords

United States ,Long Beach ,California ,Israel ,Orange County ,South Africa ,Johannesburg ,Gauteng ,Irvine ,Hebrew University ,Yerushalayim ,Joel Neutel ,Zach Herschfus ,Yaron Ilan ,Oramed Pharmaceuticals Inc ,University Of California ,Hadassah Medical School ,Vice Dean Of The Hebrew University ,Hadassah Medical Center ,Company Contact ,Nasdaq ,Memorial Research Medical Clinic In Long Beach ,Department Of Medicine ,University Of Witwatersrand ,Memorial Research Medical Clinic ,Oramed Pharmaceuticals ,Orange County Research Center ,Professor At Harvard University ,Veterans Administration Medical Center ,Exchange Commission ,Prnewswire Oramed Pharmaceuticals Inc ,Oramed Pharmaceuticals Nasdaq ,Hebrew University Hadassah Medical Center ,Hebrew University Hadassah Medical ,Vice Dean ,Visiting Professor ,Harvard University ,Study Principal Investigator ,Protein Oral Delivery ,